Adult Onset Rheumatoid Arthritis — A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis
Citation(s)
A Phase 1b Randomized, Double-blind, Placebo-controlled Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics, and Clinical Response of MEDI4920 in Subjects With Adult-onset Rheumatoid Arthritis